What is known about brain fog and cognitive difficulties in POTS, ME/CFS, fibromyalgia and long COVID?

Attention, memory and processing-speed difficulties: what studies show, without reducing brain fog to a single diagnosis.

  • 10 sources
  • 5 min read
  • Clinical review
  • Verified 9 November 2026

Key points

  • “Brain fog” is an expression used to describe difficulties with concentration, memory, finding words or slowed responses; the sources consulted use it to describe symptoms, not as the name of a disease [1, 2].
  • In POTS, a case-control study comparing 28 women with 24 controls observed lower scores in selective attention, processing speed and executive function, but not in all the cognitive domains tested [3].
  • A 2022 ME/CFS meta-analysis found differences in immediate visuospatial memory, reading speed and episodic memory, while highlighting the heterogeneity of the cognitive profile [4].
  • A 2026 meta-analysis of working memory in ME/CFS (34 studies) found a large difference for verbal working memory, but no significant difference for visual working memory [5].
  • Complaints and test results do not always match: in six adolescents with POTS referred for cognitive difficulties, standardized test results were in the average range or above, despite a major impact on schooling [6].

A descriptive expression

POTS: neuropsychological data

ME/CFS: cognitive profiles

Fibromyalgia: “fibro-fog”

Long COVID and other contexts

Interpretation and caution

References and level of evidence

  1. NICE. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NG206). NICE guideline 2021.(guideline or consensus)
    Limitations: UK guideline; not a French or US framework. Population: children, young people and adults with suspected or diagnosed ME/CFS. Read: online recommendations.
    Declared conflicts of interest: Institutional document; committee declarations not consulted
  2. CDC. Clinical Symptoms of Long COVID. CDC – Long COVID (page updated March 9, 2026) 2026.(expert opinion)
    Limitations: Clinical page listing commonly reported symptoms; gives no formal definition of long COVID and does not mention post-exertional malaise. Read: official page.
    Declared conflicts of interest: Institutional document
  3. Arnold AC, Haman K, Garland EM, Raj V, Dupont WD, Biaggioni I, Robertson D, Raj SR. Cognitive dysfunction in postural tachycardia syndrome. Clinical Science (London), 128(1):39–45 2015. DOI: 10.1042/CS20140251. PMID: 25001527.(observational study)
    Limitations: Case-control study: 28 women with POTS and 24 age- and sex-matched controls; tests performed in a semi-recumbent position. Read: abstract.
    Declared conflicts of interest: Not reviewed in the part of the source that was read
  4. Aoun Sebaiti M, Hainselin M, Gounden Y, Sirbu CA, Sekulic S, Lorusso L, Nacul L, Authier FJ. Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Scientific Reports, 12(1):2157 2022. DOI: 10.1038/s41598-021-04764-w. PMID: 35140252.(evidence synthesis)
    Limitations: Studies published from 1988 to 2019, with patients defined mainly by the 1994 CDC criteria; heterogeneous tests. Read: full text (PMC8828740).
    Declared conflicts of interest: The authors declare no conflicts of interest; funded by AFM and the COST program
  5. Penson M, Kelly K. Evaluating working memory functioning in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis. Psychology, Health & Medicine (published online January 8, 2026) 2026. DOI: 10.1080/13548506.2025.2606183. PMID: 41504224.(evidence synthesis)
    Limitations: 34 studies; full text not read. Read: abstract.
    Declared conflicts of interest: Not reviewed in the part of the source that was read
  6. Koch SA, Jarjour IT, Evankovich KD. Neurocognitive Profiles in Adolescents With Postural Tachycardia Syndrome and Perceived Brain Fog: A Preliminary Report. Pediatric Neurology, 148:128–132 2023. DOI: 10.1016/j.pediatrneurol.2023.08.011. PMID: 37703657.(exploratory finding)
    Limitations: Chart review of six adolescents from a pediatric neurology clinic; no generalization possible. Read: abstract.
    Declared conflicts of interest: Not reviewed in the part of the source that was read
  7. Assurance Maladie. Un cas particulier : le syndrome de fatigue chronique ou encéphalomyélite myalgique. ameli.fr (updated August 28, 2026) 2026.(expert opinion)
    Limitations: General-public information page; it is neither a French National Authority for Health (HAS) guideline nor a French national diagnosis and care protocol (PNDS). Read: official page.
    Declared conflicts of interest: Institutional document
  8. Haute Autorité de santé (HAS). Fibromyalgie de l'adulte : conduite diagnostique et stratégie thérapeutique. HAS (French National Authority for Health) good practice guideline (adopted June 19, 2025, published online July 10, 2025) 2025.(guideline or consensus)
    Limitations: French guideline for adults; does not automatically apply to children or outside France. Read: overview page and the “Recommendations” document (in French).
    Declared conflicts of interest: Not reviewed in the part of the source that was read
  9. Wu YL, Huang CJ, Fang SC, Ko LH, Tsai PS. Cognitive Impairment in Fibromyalgia: A Meta-Analysis of Case-Control Studies. Psychosomatic Medicine, 80(5):432–438 2018. DOI: 10.1097/PSY.0000000000000575. PMID: 29528888.(evidence synthesis)
    Limitations: 23 case-control studies published before September 2017; heterogeneous tests. Read: abstract.
    Declared conflicts of interest: Not reviewed in the part of the source that was read
  10. Nicholls T, Kelly K. Assessing working memory function in individuals with fibromyalgia: A systematic review and meta-analysis. Applied Neuropsychology: Adult (published online October 14, 2025) 2025. DOI: 10.1080/23279095.2025.2570780. PMID: 41086106.(evidence synthesis)
    Limitations: 29 studies; full text not read. Read: abstract.
    Declared conflicts of interest: Not reviewed in the part of the source that was read
Written by
AI-assisted literature research (ChatGPT) and AI-assisted writing (Claude)
Editor
Jean Viry-Babel
Review status
Clinical review: Dr Françoise Charmoillaux (anesthesiologist)
Approved on
9 November 2026
Literature search
8 November 2026
Last verified
9 November 2026
Geographic scope
international, United States, France, United Kingdom
Audience
everyone
Conflicts of interest
No known financial ties. Separately, the publisher is developing a personal approach to these conditions under the name Connected Conditions, which is not cited here (see the legal notice).
Limitations of this page
General synthesis: cannot be used to interpret a neuropsychological assessment or to attribute a cognitive complaint to a disease. Several studies were read from their abstract only; group averages cannot be applied to an individual. Page not reviewed by a neurologist or neuropsychologist.